LA Billionaire's Biotech Firm Inks With Alexandria

Alexandria Real Estate Equities strikes again. This time, in the former Novartis space in its Nautilus campus.

NantKwest Inc inked a deal for 44,700 SF at 3530 John Hopkins Ct, part of the complex once used by Merck & Co and Novartis, according to filings with the SEC. Alexandria, which bought the Nautilus project in 2012 and renovated into a life science complex, inked the sizable deal with NantKwest this past summer for both office and R&D uses, according to docs.

This deal is part of what Alexandria's Dan Ryan recently called the best leasing quarter in 20 years. The firm also secured a build-to-suit with Eli Lilly at its Campus Point Drive project. This deal for NantKwest comes on the heels of that biotech's recent IPO, which secured a market cap of more than $2B. NantKwest, controlled by LA billionaire Patrick Soon-Shiong (here), makes cancer immunotherapy medicines.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Diego Newsletters
Related Stories

Fertility Provider Opens Clinic At 1900 Lawrence Office Tower: The Denver Deal Sheet

Office Revenues Are Failing To Keep Pace With Expenses

Security Tech Firm Plans Loudoun HQ Move: The D.C. Deal Sheet

Stephen Ross Expands Palm Beach Empire With Massive Boca Raton Campus

25 Years After 9/11, Lower Manhattan Is Finally Firing On All Cylinders

Tishman Speyer Seeks $92M Tax Break For Next Hudson Yards Office Tower

Charles Cohen Plans $350M Office Project After Resolving Debt Ordeal

Report Finds Hybrid Work Creates New Opportunities For Women In Real Estate

SL Green Selling SoHo Building For $226M

The Difference Between Service And Hospitality That Makes A Flexible Workspace A Success

Center City Office Demand Starts Spilling From Trophy To Class-A Despite Debt Issues

EXCLUSIVE: Georgia-Pacific Scraps Conversion Plans For Its Atlanta HQ